Bernard Lim Buys 10,000 Shares of Cardiol Therapeutics Inc. (TSE:CRDL) Stock

Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Bernard Lim bought 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The shares were bought at an average cost of C$1.95 per share, for a total transaction of C$19,500.00.

Cardiol Therapeutics Trading Up 0.5 %

CRDL opened at C$1.96 on Thursday. The company has a fifty day moving average price of C$2.40 and a two-hundred day moving average price of C$2.71. Cardiol Therapeutics Inc. has a 1-year low of C$1.07 and a 1-year high of C$4.26. The company has a market cap of C$136.96 million, a P/E ratio of -4.45 and a beta of 0.70. The company has a current ratio of 2.39, a quick ratio of 6.84 and a debt-to-equity ratio of 1.07.

About Cardiol Therapeutics

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.